Cargando…
Low DMSO Cryopreservation of Stem Cells Enabled by Macromolecular Cryoprotectants
[Image: see text] Mesenchymal stromal (stem) cells have potential in regenerative medicine and modulating the immune system. To deliver any cell-based therapy to the patient, it must be cryopreserved, most commonly in DMSO, which impacts cell function and causes clinical side effects. Here we report...
Autores principales: | Murray, Kathryn A., Tomás, Ruben M. F., Gibson, Matthew I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509910/ https://www.ncbi.nlm.nih.gov/pubmed/32984779 http://dx.doi.org/10.1021/acsabm.0c00638 |
Ejemplares similares
-
Assay-ready Cryopreserved
Cell Monolayers Enabled
by Macromolecular Cryoprotectants
por: Tomás, Ruben M. F., et al.
Publicado: (2022) -
Cryopreservation
of Liver-Cell Spheroids with Macromolecular
Cryoprotectants
por: Bissoyi, Akalabya, et al.
Publicado: (2023) -
Red Blood Cell Cryopreservation with Minimal Post-Thaw
Lysis Enabled by a Synergistic Combination of a Cryoprotecting Polyampholyte
with DMSO/Trehalose
por: Murray, Alex, et al.
Publicado: (2021) -
Polyampholytes as Emerging Macromolecular Cryoprotectants
por: Stubbs, Christopher, et al.
Publicado: (2019) -
Combinatorial Biomaterials Discovery Strategy to Identify
New Macromolecular Cryoprotectants
por: Stubbs, Christopher, et al.
Publicado: (2020)